Search Results

“I got to know computational chemistry through a project on BCL2 proteins and drug discovery… I was in drug discovery pipelines. By bridging structural prediction, molecular dynamics, and ligand discovery, his work not only deciphers leveraging computational structure-based tools and develop specific protocols to accelerate OR ligand discovery GPCR Podcast? Leave a Review.

Deep-dive sessions focused on real pharmacology, real drug discovery challenges, and real translational From Target to Candidate Receptor biology grounded in drug discovery. , pharmacology, signaling, and drug discovery. These webinars are designed to support ongoing scientific development in GPCR pharmacology and drug discovery on receptor pharmacology and drug discovery.

<< Back to podcast list Strategic Partner(s) Empowering Drug Discovery for the GPCR Community with Dr GPCR Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass ➚ Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Enjoying GPCR Podcast? Leave a Review.

, pharmacology, signaling, and drug discovery. discovery, not just academic theory. discovery. These webinars are designed to support ongoing scientific development in GPCR pharmacology and drug discovery on receptor pharmacology and drug discovery.

signaling and function NovoiSMART - A new platform for GPCR antibody drug discovery Gavin Zhang Read Signaling and Pharmacology-Enabling Drug Discovery Fabian Pohl Structural Determinants Of GAIN Domain Stephanie Häfner The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Anne Bormann Placantonakis Antibody-drug conjugates targeting CD97 in glioblastoma Gabriela Aust Critical role for map of thermogenic fat Gavin Zhang NovoiSMART - A new platform for GPCR antibody drug discovery

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program - A new platform for GPCR antibody drug discovery Abstract Developing monoclonal antibody drugs against GPCRs and other multi-pass transmembrane targets, such as ion channels, remains a significant challenge technology, demonstrated in the success of COVID-19 vaccines, is emerging as a promising method for antibody discovery developing highly specific antibodies for complex targets, with implications for overcoming challenges like drug

Be Discoverable When GPCR Teams Are Actively Evaluating Services and Tools Reach 1400+ GPCR researchers discovery teams can quickly identify relevant capabilities when evaluating tools, technologies, or CRO As a CRO partner, you'll gain trusted access to an engaged audience of biotech teams and drug discovery These channels are used to support discovery and evaluation — helping teams understand what you offer GPCR platform as a valued partner ✓ Share insights on product launches, scientific discoveries, or customer

and drug discovery innovation. << Back to podcast list Strategic Partner(s) From Curiosity to Breakthrough : Ajay Yekkirala on GPCR Innovation What if the key to safer, more effective drugs lies in asking the discovery. Ajay reveals how humility, curiosity, and collaboration fuel the future of drug discovery. Seeing the limits of traditional drug discovery, he later co-founded Superluminal Medicines, a company

Register now and shape the future of drug discovery! obesity drug discovery: Cell-based assays for GLP-1 and the G-Suite - Online March 17 - 21, 2025 | 2nd GPCR signaling and drug discovery Symposium & Workshop - Brazil NEW April 1 - 3, 2025 | 2nd Peptide-Based - 30, 2025 | AACR Annual Meeting 2025 - USA NEW May 1 - 2, 2025 | 5th Ace Drug Discovery Summit 2025 Drug Discovery Summit - USA June 22 - 26, 2025 | G Protein-coupled Receptor Kinases and Arrestins -

Drug Discovery with Tom Sakmar & Ilana Kotliar In this episode, host Dr. This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream multiplex strategy aligns perfectly with this evolution, providing scalable approaches to biological discovery Key Takeaway This episode is more than a conversation — it’s a masterclass in tool-driven discovery , discovery and chemical biology research, mainly involving GPCRs.

Discovery. David has over 20+ years of experience working in a drug discovery environment mainly in a specialist Discovery that he was awarded in 2020. discovery. " Dr. GPCR Podcast? Leave a Review.

Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular He continues to pioneer in drug discovery studying GPCRs and other target classes. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular He continues to pioneer in drug discovery studying GPCRs and other target classes. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

pharmacology workflows. < Back Using iPSC-derived models to study GPCR function April 16, 2026 10 AM Introduction Drug discovery pipelines increasingly depend on screening platforms designed to identify Yet despite advances in screening technologies, the translation of these discoveries into clinical success integrated to monitor signaling pathways, and how such systems can support more translationally relevant drug discovery workflows.

As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery stabilization and structure-based drug design. Marshall is the VP Head of Neuroscience Discovery and Head of Discovery UK, Global Head of Neuroscience discovery research leading teams in West Point, Boston, and London at MSD. GPCR Podcast? Leave a Review.

with numerous pharma and biotechs in understanding and applying in vitro pharmacology data to advance drug discovery. He specializes in kinetic analysis of drug action and is known for applying binding kinetics to the development He guided the in vitro biology efforts of the company for numerous drug discovery campaigns. GPCR Member ResearchGate Dr.

discovery campaigns. I have extensive training in computer-aided drug design. discovery. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Can models predict drug outcomes? Jens Carlsson shares how GPCR modeling is moving from explanation to real prediction in drug discovery Bridging computation, chemistry, and pharmacology is key to speeding up drug discovery. discovery. science, and what that means for the future of drug discovery.

Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused spent significant time in the industry studying membrane proteins, antibodies, and HTS methods for drug discovery. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

target discovery. GPCR Targeted Drugs and Gene Regulation in Cancer Cells Mike presented research on the effect of GPCR-targeted lab, which led to the discovery of potential tumor suppressors and oncogenes in melanoma. Scientific Journey and Drug Discovery Challenges Mike shared significant moments in his scientific journey , including the discovery of RGS proteins and its impact on his research approach.

Michelle Halls shares how dissecting the spatial organization of GPCR signaling opens new doors in drug discovery. From early discoveries in cyclic AMP signaling to uncovering ultrasensitive receptor responses at femtomolar the Guest Michelle Halls is an Associate Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute of Pharmaceutical Sciences.

Dr GPCR is a 501(c)(3) non-profit. Support the GPCR Community — Empower the Next Generation of Discovery Your donation helps us serve the global GPCR community better — by upgrading the Dr GPCR University, creating more learning opportunities research, collaboration, and discovery. Together, we can accelerate GPCR discoveries and develop more effective drugs for everyone. 👉 Donate

and in vitro drug discovery. Icahn School of Medicine at Mount Sinai in NYC, where I have been working on structure-function and drug discovery of GPCRs and transporters. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

receptors involved in many, if not all, physiological responses, with the ultimate goal of improving drug in-cellulo measurement of protein-protein interactions, receptor trafficking and signalling, useful for drug discovery programs. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

together to advance biology and therapeutics. 📚 Learn faster. 🤝 Connect deeper. 🔬 Drive discoveries helps shape the future of discovery. Explore 200+ expert talks that bring GPCR discoveries to life From structural biology to therapeutics every scientist needs to see pharmacology clearly, from core principles to the hidden variables of drug behaviors, and the strategies to drive successful drug discovery projects.

engaged in researching molecular mechanisms that govern human (patho-)physiology and their interplay with drugs I aim to discover new therapeutic approaches, and druggable molecules or refine canonical drug targets to create drugs with fewer adverse effects. I want to combine experimental approaches with data-driven discovery and adopt data science methodology GPCR Podcast? Leave a Review.

Chris Langmead is Professor, Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery ) and is the co-founder and CEO of Phrenix Therapeutics, a biotech spin-out from the Neuromedicines Discovery Therapeutics Ltd., a UK-based biotechnology company (2009-2012), where he was responsible all of the company’s discovery He is an acknowledged expert in drug discovery, particularly in the field of psychiatry, where he has He has published over 70 research articles, reviews and book chapters on drug discovery, which have been

in life science innovation, delivering tools and technologies that bridge the gap between discovery unwavering focus on precision, Revvity empowers scientists to simplify complex workflows, accelerate discovery designing the next generation of therapeutics, Revvity isn’t just a provider—they’re your partner in discovery GPCR, the global nonprofit platform dedicated to advancing GPCR research and drug discovery, is proud Learn how pH Sense changes the game for drug discovery. Dr.

Eleonora Comeo About this episode Eleonora Comeo is a doctoral candidate in Medicinal Chemistry and Drug Discovery in the joint program of the University of Nottingham in the UK and Monash University in Australia to work with GPCR scientists on 2 continents. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing She oversaw early discovery programs IL-23 p19 and IL23 p19/IL-17 bispecifics. She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.